Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort studyNicole M. Kuderer, Kerry L. Reynolds, Toni K. Choueiri et al.|The Lancet|2020Cited by 1.8k
Myocarditis in Patients Treated With Immune Checkpoint InhibitorsSyed Mahmood, Tomas G. Neilan, Sachin Shah et al.|Journal of the American College of Cardiology|2018Cited by 1.5k
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statementJoerg Herrmann, Peter Valent, Daniel J. Lenihan et al.|European Heart Journal|2021Cited by 589
Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic PlaqueZsófia D. Drobni, Tomas G. Neilan, Raza M. Alvi et al.|Circulation|2020Cited by 535
Germline variants associated with toxicity to immune checkpoint blockadeStefan Groha, Alexander Gusev, Sarah Abou Alaiwi et al.|Nature Medicine|2022Cited by 106